Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Capricor Therap (CAPR)

Capricor Therap (CAPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Capricor: Q1 Earnings Snapshot

Capricor: Q1 Earnings Snapshot

CAPR : 4.72 (-2.48%)
Capricor: Q4 Earnings Snapshot

Capricor: Q4 Earnings Snapshot

CAPR : 4.72 (-2.48%)
Capricor: Q3 Earnings Snapshot

Capricor: Q3 Earnings Snapshot

CAPR : 4.72 (-2.48%)
24 Cent Micro Cap May Hold The Key To Potential Breakthrough In Acute Spinal Cord Injury

An estimated 250,000-500,000 people experience a %SpinalCordInjury (SCI) annually, with roughly 17,000 new cases in the US and 27,000 in Europe each year, leaving many of those people permanently confined...

TECH : 71.24 (-0.52%)
LLY : 906.71 (-0.84%)
CAPR : 4.72 (-2.48%)
NRX.VN : 0.750 (+13.64%)
NRX : 0.14 (+7.69%)
PARS : 0.0200 (-48.72%)
Capricor: Q2 Earnings Snapshot

Capricor: Q2 Earnings Snapshot

CAPR : 4.72 (-2.48%)
Capricor: Q1 Earnings Snapshot

Capricor: Q1 Earnings Snapshot

CAPR : 4.72 (-2.48%)
Capricor: Q4 Earnings Snapshot

Capricor: Q4 Earnings Snapshot

CAPR : 4.72 (-2.48%)
Capricor: Q3 Earnings Snapshot

Capricor: Q3 Earnings Snapshot

CAPR : 4.72 (-2.48%)
Capricor Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update

-First Patient Treated in HOPE-3, the Pivotal Phase 3 Clinical Trial of CAP-1002 in Duchenne Muscular Dystrophy- -Positive One-Year...

CAPR : 4.72 (-2.48%)
Capricor Therapeutics to Present Second Quarter 2022 Financial Results and Recent Corporate Update on August 10

Company to Host Conference Call, August 10, 2022, at 4:30 p.m. ET...

CAPR : 4.72 (-2.48%)

Barchart Exclusives

Is This Copper Mining Stock a Buy for Its Fat Dividend?
Southern Copper has a higher dividend yield compared to other copper mining companies. However, its valuations are also on the higher side, making a closer examination of the risk-reward necessary for prospective investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar